ERBB2 and hepatocellular carcinoma: Considering the expression of stemness genes, U0126 inhibition of ERK activation resulted in mixed responses in HCC cell lines, with increased HER2 expression and decreased SOX9 and c-Myc expression (Figures 5E–H).